New research has found the world’s first portable MRI machine can accurately detect ischemic strokes. The machine was cleared for use by the US Food & Drug Administration (FDA) in 2020 and researchers ...
Expert Rev Cardiovasc Ther. 2009;7(1):29-48. Several additional trials are using identification of a penumbra by neuroimaging for the inclusion of patients. The ReoPro Retavase Reperfusion of Stroke ...
Noncontrast CT is commonly used to diagnose acute stroke because of its ability to detect acute hemorrhage, although it is less sensitive for early detection of ischemic stroke. The American Academy ...
Among patients with acute ischemic stroke, diagnostic imaging with CT alone was noninferior to initial CT plus MRI for discharge and 1-year clinical outcomes, in a new study. The rates of death or ...
Please provide your email address to receive an email when new articles are posted on . The portable MRI detected a high percentage of stroke-related infarct. Hyperfine has “practical advantages” over ...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop® system is a promising tool for enabling critical stroke treatment choices in ...
Patients with acute ischemic stroke (AIS) did not have worse outcomes when a CT-only imaging strategy determined the course of their treatment, according to a small observational study. Those skipping ...
Portable magnetic resonance imaging (MRI) machines, an emerging technology that makes medical imaging accessible even in remote locations, detected ischemic strokes, or strokes caused by clotting, in ...
Stroke is more common in adults, however, it can also happen in children and adolescents. Some of the most common causes of ...
Annually, an estimated 1 million patients undergo heart surgery worldwide. Unfortunately, stroke continues to be a frequent complication of cardiac surgery, with the specific cerebrovascular risk ...
Thrombectomy is currently recommended for eligible patients with stroke who are treated within 6 hours after the onset of symptoms. We conducted a multicenter, randomized, open-label trial, with ...